title: Relationship of cardiac sympathetic nerve innervation and excitability to cardiac hypertrophy in very elderly male hypertensive patients.
abstract: BACKGROUND
  Our study aimed to disclose the relationship of cardiac sympathetic nerve innervation and excitability to myocardial hypertrophy in very old elderly male hypertensive patients with low serum testosterone level.
  
  
  METHODS
  A total of 80 elderly male hypertensive patients aged from 80 to 95 years were recruited. Heart rate variability is determined by 24 h dynamic electrocardiogram and heart rate variability analysis system. Cardiac function and left ventricular mass index were determined using color Doppler ultrasound.
  
  
  RESULTS
  Standard deviation of all normal sinus R-R intervals over 24 h (SDNN) significantly decreased in hypertensive cardiac hypertrophy patients as compared with those without cardiac hypertrophy. SDANN and Standard deviation of the average normal sinus R-R intervals for all 5-min segment index, time-domain index reflecting sympathetic nerve tension, obviously decreased and LFnu and LFnu/HFnu, frequency-domain index representing sympathetic nerve excitability, significantly increased in hypertensive cardiac hypertrophy patients as compared with those without cardiac hypertrophy. Myocardial norepinephrine content significantly increased while tyrosine hydroxylase expression significantly lowered in hypertensive cardiac hypertrophy patients, and a negative correlation between myocardial tyrosine hydroxylase expression and myocardial norepinephrine content was present. Serum total testosterone level decreased in hypertensive cardiac hypertrophy patients and was an independent risk factor for the increase in myocardial norepinephrine content and decrease in tyrosine hydroxylase expression.
  
  
  CONCLUSIONS
  These data confirm that cardiac sympathetic nerve hypoinnervation and relative increase in cardiac sympathetic nerve excitability are closely related to cardiac hypertrophy in very old hypertensive patients. A lower serum total testosterone level was the independent risk factor of cardiac sympathetic nerve hypoinnervation and relative increase in excitability in very old male hypertensive patients.
authors.affiliation: Division of Geriatric Cardiology, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China.
authors.forename: Shijun
authors.initials: S
authors.lastname: Li
authors.forename: Li
authors.initials: L
authors.lastname: Zhang
authors.forename: Yuanyuan
authors.initials: Y
authors.lastname: Guo
authors.forename: Xiaoying
authors.initials: X
authors.lastname: Li
mesh_terms: D000367:Age Factors; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D015536:Down-Regulation; D018618:Echocardiography, Doppler, Color; D015716:Electrocardiography, Ambulatory; D006321:Heart / Q000294:innervation*; D006339:Heart Rate; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000097:blood / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology; D008297:Male; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D012307:Risk Factors; D012737:Sex Factors; D013318:Stroke Volume; D013564:Sympathetic Nervous System / Q000378:metabolism / Q000503:physiopathology*; D013739:Testosterone / Q000097:blood; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D016277:Ventricular Function, Left
chemical_list: D015415:Biomarkers; D013739:Testosterone; D014446:Tyrosine 3-Monooxygenase; D009638:Norepinephrine
references.citation: Circulation. 2003 Aug 5;108(5):560-5
references.pmid: 12847071
references.citation: Circulation. 1994 Apr;89(4):1717-24
references.pmid: 8149537
references.citation: Auton Neurosci. 2010 Aug 25;156(1-2):27-35
references.pmid: 20335077
references.citation: Anat Rec. 2001 Oct 1;264(2):169-82
references.pmid: 11590594
references.citation: Hypertens Res. 1999 Sep;22(3):217-21
references.pmid: 10515445
references.citation: Pol J Pharmacol. 2004 Sep-Oct;56(5):509-18
references.pmid: 15591638
references.citation: J Auton Nerv Syst. 1979 Dec;1(2):139-47
references.pmid: 553089
references.citation: Acta Cardiol. 2004 Feb;59(1):47-50
references.pmid: 15030134
references.citation: Eur J Pharmacol. 2009 Oct 1;619(1-3):68-74
references.pmid: 19665014
references.citation: Psychopharmacol Bull. 2007;40(4):205-18
references.pmid: 18227789
references.citation: Circulation. 1996 May 1;93(9):1667-76
references.pmid: 8653872
references.citation: Hypertens Res. 2005 Aug;28(8):625-30
references.pmid: 16392765
references.citation: J Mot Behav. 2010 May-Jun;42(3):151-5
references.pmid: 20363715
references.citation: Br J Pharmacol. 2008 Feb;153(4):693-709
references.pmid: 18157169
references.citation: Int Braz J Urol. 2011 Sep-Oct;37(5):591-7
references.pmid: 22099270
references.citation: Am J Hypertens. 1998 Feb;11(2):147-54
references.pmid: 9524042
references.citation: Neuroscience. 2001;108(2):331-40
references.pmid: 11734365